Patents
Sitemap › C12 - Biochemistry; Beer; Spirits; Wine; Vinegar; Microbiology; Enzymology; Mutation or genetic engineering › C12N - Micro-organisms or enzymes; Compositions thereof; Propagating, preserving, or maintaining micro-organisms; Mutation or genetic engineering; Culture media › C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629)
09/2005
09/15/2005US20050202516 Methods and compositions for neural progenitor cells
09/15/2005US20050202496 Secreted and transmembrane polypeptides and nucleic acids encoding the same
09/15/2005US20050202481 Novel polypeptide ESDN, polynuleotides encoding the polypeptide, and utility of the polypeptide
09/15/2005US20050202475 Using chimeric membrane protein as diagnostic/prognostic indicator of cell proliferative disorders
09/15/2005US20050202474 Phosphodiesterases
09/15/2005US20050202454 "STRAP" and "STEAP"(six transmembrane (epithelial) antigen of the prostate)
09/15/2005US20050202452 Assay determining the activity of an agent to decrease cell division; contacting protein capable of superoxide production with compound of interest and and measuring the ability of the agent to decrease superoxide production, inhibit diaphorase activity or bind the protein
09/15/2005US20050202428 Notch signaling inhibitory RNA sequences for use in treatment and prevention of cell proliferative and developmental disorders
09/15/2005US20050202426 Whole cell engineering using real-time metabolic flux analysis
09/15/2005US20050202411 Preparing biopsy of tumorous tissue and monitoring chemosensitivity to anticarcinogenic agents; antitumor agents
09/15/2005US20050202410 Precise efficacy assay methods for active agents inlcluding chemotherapeutic agents
09/15/2005US20050202058 Cell-seeded extracellular matrix grafts
09/15/2005US20050202048 Chlamydia antigens and vaccine uses of the protein
09/15/2005US20050202042 Toxin B repeating units (rBRU) of Clostridium difficile and an antigen of a pathogenic microorganism other than C. difficile; eliciting T-cell dependent and antibody responses
09/15/2005US20050202035 Stress protein complex; a grp170 polypeptide and an immunogenic polypeptide; antitumor
09/15/2005US20050202024 Protein sequences containing antigenized antibodies for foot-and-mouth disease
09/15/2005US20050202021 Anti-cancer antibodies with reduced complement fixation
09/15/2005US20050202013 Novel Th2-specific molecules and uses thereof
09/15/2005US20050202004 Administering chimeric proteins, having a portion of the VH or VL region of a immunoglobulin molecule from B cells from a patient having a B cell mediated pathology; proteins conjugated to an immunogenic carrier, keyhole-limpet hemocyanin (KLH)
09/15/2005US20050201995 Neuronal cell comprising a REST-transactivator; reducing neuronal damage, neuronal loss or neurodegenerative disease
09/15/2005US20050201992 Culture with human dendritic cells wherein the hybrid cells were generated by fusing tumor cells dissociated from a tumor by mechanical dissociation with a highly enriched population of human B-cells; avoiding the problems of immune suppression, autoimmune reactions, and self-recognition; kits; antitumor
09/15/2005US20050201991 Stem cell culture
09/15/2005US20050201990 Endothelial progenitor cells and methods of use thereof
09/15/2005US20050201988 A pegylated red blood cell of a polyethylene glycol attached to a thiolated amino group on a membrane protein of the red blood cell; reacting a lysine residue with 2-iminothiolane or dithio sulfosuccinimidyl proprionate, a linker/polymer; blood transfusions; antiagglomerants; shelf life; oxygen demand
09/15/2005US20050201986 Cell targeting compositions and methods of using the same
09/15/2005US20050201985 Modified adenoviral vectors for use in vaccines and gene therapy
09/15/2005US20050201977 Amino-terminally truncated MCP-2 as chemokine antagonists
09/15/2005US20050201932 Drug delivery using Polymeric immunoglobulin receptor (pIgR) which when cleaved has a stalk region which remains attached to the cell and a secretory component (SC) which exists in an organ of interest in several forms
09/15/2005DE102004037184B3 Tissue transplant construct, useful especially for correcting defects in the bladder, comprises collagen-containing membrane supporting layers of organ-specific cells, with the outermost layer fully differentiated
09/15/2005CA2599823A1 Reverse-flow perfusion of three-dimensional scaffolds
09/15/2005CA2563397A1 Adzymes and uses thereof
09/15/2005CA2560066A1 Natural igm antibodies and inhibitors thereof
09/15/2005CA2559110A1 Endothelial progenitor cells and methods of use thereof
09/15/2005CA2558596A1 Anti fk778 antibodies and high sensitive immunoassay methods
09/15/2005CA2558593A1 .beta.-fructofuranosidase variants
09/15/2005CA2558586A1 Recombinant varicella-zoster virus
09/15/2005CA2558520A1 Serum-free suspension culture system for mesenchymal progenitor cells
09/15/2005CA2558436A1 Method of proliferating precursor cells
09/15/2005CA2558382A1 Methods and compositions for hybrid cell vaccines for the treatment and prevention of cancer
09/15/2005CA2558152A1 Transgenic expression constructs for vegetative plant tissue specific expression of nucleic acids
09/15/2005CA2558056A1 Treatment of spinal conditions
09/15/2005CA2557819A1 Magnetic device for isolation of cells and biomolecules in a microfluidic environment
09/15/2005CA2557788A1 Mutein of a bone morphogenetic protein and use thereof
09/15/2005CA2556790A1 Enzyme-prodrug therapy for prosthetic joint repair
09/15/2005CA2556688A1 Cellular tissue culture systems for high-volume processing
09/15/2005CA2530514A1 Cell therapy formulation method and composition
09/15/2005CA2500926A1 Tumor/b-cell hybrid cells and uses thereof
09/14/2005EP1574579A2 Outer surface proteins, their genes, and their use
09/14/2005EP1574578A1 Monomeric protein of the TGF-beta family
09/14/2005EP1574577A2 Growth differentiation factor-11
09/14/2005EP1574571A1 Germ-responsive promoter
09/14/2005EP1573314A2 Transgenic mice expressing human cd20
09/14/2005EP1573313A2 Transgenic mice expressing human cd20 and/or cd16
09/14/2005EP1573060A1 Haplotype partitioning in the proximal promoter of the human growth hormone (gh1) gene
09/14/2005EP1573033A2 Animal genotyping method
09/14/2005EP1573028A2 A nucleic acid encoding a g-protein-coupled receptor, and uses thereof
09/14/2005EP1573026A2 Mre11: modulation of cellular proliferation
09/14/2005EP1573024A2 Nuleic acids and corresponding proteins useful in the detection and treatment of various cancers
09/14/2005EP1573023A2 Nucleic acid and corresponding protein entitled 162p1e6 useful in treatment and detection of cancer
09/14/2005EP1573022A2 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
09/14/2005EP1573016A2 Gene reporter assay, kit, and cells for determining the presence and/or the level of a molecule that activates signal transduction activity of a cell surface protein
09/14/2005EP1573010A1 Methods and means for modulating cellulose biosynthesis in fiber producing plants
09/14/2005EP1572995A2 Novel proteins and nucleic acids encoding same
09/14/2005EP1572989A1 Gen 2.2 dendritic cell line
09/14/2005EP1572988A1 Culture medium composition, culture method, and myoblasts obtained, and their uses
09/14/2005EP1572986A1 Restoration of methylation states in cells
09/14/2005EP1572984A2 Methods of preparing feeder cells-free, xeno-free human embryonic stem cells and stem cell cultures prepared using same
09/14/2005EP1572983A1 Culture chamber for biologicals
09/14/2005EP1572971A2 Methods of generating high-production of antibodies from hybridomas created by in vitro immunization
09/14/2005EP1572969A2 Method for preparing cell cultures from biological specimens for chemotherapeutic and other assays
09/14/2005EP1572968A2 Lutzomyia longipalpis polypeptides and methods of use
09/14/2005EP1572967A2 Il-1 receptor based antagonists and methods of making and using
09/14/2005EP1572966A2 Complete biosynthetic gene set for synthesis of polyketide antibiotics, including the albicidin family, resistance genes and uses thereof
09/14/2005EP1572963A2 Carbohydrate-based synthetic vaccines for hiv
09/14/2005EP1572949A2 Maintenance of islet cells
09/14/2005EP1572943A2 Circular nucleic acid vectors, and methods for making and using the same
09/14/2005EP1572942A2 Live replicating spumavirus vector
09/14/2005EP1572941A2 Novel flavivirus antigens
09/14/2005EP1572940A2 Ribulose 1,5-bisphosphate carboxylase/oxygenase polypeptides and related polynucleotides
09/14/2005EP1572939A2 Her-2 receptor tyrosine kinase molecules and uses thereof
09/14/2005EP1572937A2 Motif-grafted hybrid polypeptides and uses thereof
09/14/2005EP1572935A2 Methods of making hypermutable cells using pmsr homologs
09/14/2005EP1572934A2 Follistatin domain containing proteins
09/14/2005EP1572930A2 Albumin-fused kunitz domain peptides
09/14/2005EP1572922A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
09/14/2005EP1572916A2 Nucleic acid and corresponding protein entitled 98p4b6 useful in treatment and detection of cancer
09/14/2005EP1572914A2 Lambda integrase mediated recombination in plants
09/14/2005EP1572912A2 Selection free growth of host cells containing multiple integrating vectors
09/14/2005EP1572910A2 Signal for packaging of influenza virus vectors
09/14/2005EP1572909A2 A follistatin domain containing protein
09/14/2005EP1572907A2 Molecules interacting with casl (mical) polynucleotides, polypeptides, and methods of using the same
09/14/2005EP1572902A2 HIGH POTENCY siRNAS FOR REDUCING THE EXPRESSION OF TARGET GENES
09/14/2005EP1572898A2 Novel proteins and nucleic acids encoding same
09/14/2005EP1572895A2 Methods for producing hyaluronan in a recombinant host cell
09/14/2005EP1572891A2 Bone anti-resorptive compounds
09/14/2005EP1572890A2 Slc7s as modifies of the p53 pathway and methods of use
09/14/2005EP1572889A2 Nucleic acid and amino acid sequences encoding high-level expressor factor viii polypeptides and methods of use
09/14/2005EP1572887A2 Neural regeneration peptide and methods for their use in treatment of brain damage
09/14/2005EP1572885A2 Methods for treating diabetes and other blood sugar disorders
09/14/2005EP1572883A2 Human cytokine receptor
1 ... 970 971 972 973 974 975 976 977 978 979 980 981 982 983 984 985 986 987 988 989 990 ... 1827